Get started
TopgOptions

ARDX Ardelyx FDA bad news. Last support for bounce

Short
Ardelyx, Inc. (NASDAQ:ARDX)  
TopgOptions  
NASDAQ:ARDX   Ardelyx, Inc.
Trend Analysis Technical Indicators Fundamental Analysis ARDX ardelyx fda fdaapproval SELL sellsignal selloff signal signals
8
4
trendanalysis indicator fundamental ardx ardelyx fda fdaapproval sell sellsignal selloff signal signals
The FDA is unlikely to approve Ardelyx`s drug for dialysis patients.
Ardelyx received a letter from the FDA stating that deficiencies in the information provided had been found that would preclude discussion of approvals Ardelyx has sought.

The most likely target is the 1.6usd support line from which it can bounce up.



BUYSELL indicators tradingindicators.store/
TRADING COURSE bit.ly/tradex
Private Signals www.patreon.com/PremiumOptionsSignals
RESULTS www.bit.ly/topgx
1%/DAY: bit.ly/3F56VTW
BYBIT partner.bybit.com/b/37880

Related Ideas

TopgOptions
ARDX Ardelyx Options Ahead of Earnings
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.